Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

University Start-Up Developing Inhaled Gene Therapies

Inspecting lung X-rays

A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies

Venture Firm, Cancer Center Start Antibody Biotech Company

Antibody illustration

A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company

Company Gains Ultrasound-Linked Drug Capsule Technology

DNA bubbles illustration

A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology

Companies to Assess Ovarian Health Biotech Drug

Women silhouettes

A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug

Bio-Friendly Plant Nutrient Delivery Patent Awarded

Seedlings in soil

A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded

Patent Issued for Synthetic Peptide Chain Techniques

U.S. Patent and Trademark Office

A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Gene therapy graphic

Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Start-Up Licenses Protein Therapy Tech, Raises $50M

Lab flasks

A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M

Start-Up Licensing Antibody Eye Drops for Dry Eye Disease

Red-blue-green eye

An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease. . . . → Read More: Start-Up Licensing Antibody Eye Drops for Dry Eye Disease